Summary
This prediction ended on 19.02.18 with a price of €98.83. With a performance of -8.28%, the BUY prediction by piccolo90 finished with a loss. piccolo90 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 0.192% | 0.192% | -47.607% | -49.740% |
| iShares Core DAX® | -0.079% | -3.039% | 13.992% | 14.646% |
| iShares Nasdaq 100 | 0.247% | 6.421% | 36.232% | 55.769% |
| iShares Nikkei 225® | 1.918% | 0.675% | 10.784% | 5.212% |
| iShares S&P 500 | 0.146% | 4.708% | 29.832% | 48.430% |
Comments by piccolo90 for this prediction
In the thread Bayer AG diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 29.11.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 121.57€ zu.
(Vom Mitglied beendet)